Objective: The aim of this study is to evaluate the relationship between Lund-Mackay scores, osteitis severity, and neutrophil lymphocyte ratio, platelet lymphocyte ratio, basophil lymphocyte ratio, eosinophil lymphocyte ratio, and systemic immune inflammation index in patients with chronic rhinosinusitis with nasal polyps.
Methods: Patients who were diagnosed with chronic rhinosinusitis with nasal polyps and underwent endoscopic sinus surgery between 2014 and 2020 were evaluated retrospectively. Lund-Mackay scores and osteitis severity (Hounsfield Unit) were determined separately for each nasal cavity by examining preoperative computed tomography images. Lund-Mackay and Hounsfield Unit scores were compared with the preoperative neutrophil lymphocyte ratio, platelet lymphocyte ratio, basophil lymphocyte ratio, eosinophil lymphocyte ratio, and systemic immune inflammation index.
Results: A total of 39 patients (24 males, 15 females) (78 sides) enrolled in the study. There was a positive correlation between right-sided Lund-Mackay scores and ipsilateral Hounsfield Unit (r = 0.343, P = .033). Similarly, there was a positive correlation between left nasal cavity Lund-Mackay scores and ipsilateral Hounsfield Unit (r = 0.376; P=.018). No statistically significant correlation between Lund-Mackay scores and Hounsfield Unit values, and neutrophil lymphocyte ratio, platelet lymphocyte ratio, basophil lymphocyte ratio, eosinophil lymphocyte ratio, and systemic immune inflammation index values were detected.
Conclusion: In the present study, no correlation between chronic rhinosinusitis with nasal polyps severity and systematic inflammatory markers was demonstrated.
Chronic rhinosinusitis with nasal polyps Lund-Mackay score osteitis systemic inflammatory ratio.
| Primary Language | English |
|---|---|
| Subjects | Otorhinolaryngology |
| Journal Section | Original Article |
| Authors | |
| Publication Date | August 28, 2023 |
| Published in Issue | Year 2023 Volume: 6 Issue: 2 |
You can find the current version of the Instructions to Authors at: https://www.eurjrhinol.org/en/instructions-to-authors-104
Starting on 2020, all content published in the journal is licensed under the Creative Commons Attribution-NonCommercial (CC BY-NC) 4.0 International
License which allows third parties to use the content for non-commercial purposes as long as they give credit to the original work. This license
allows for the content to be shared and adapted for non-commercial purposes, promoting the dissemination and use of the research published in
the journal.
The content published before 2020 was licensed under a traditional copyright, but the archive is still available for free access.